analog scale, cough severity index and cough quality of life, shorter duration improvement, and minimal side effects in the interventional group.#We suggest that montelukast may be effective to reduce the duration and severity of the persistent post-COVID-19 cough and further improve quality of ...
Post-Covid-19 syndrome lasts for several weeks or several months after recovery. Symptoms include respiratory ones such as cough, sputum, difficulty breathing, aftereffects of pneumonia, neurological sequelae such as headache, dizziness, sleep disturbance, systemic symptoms such as chronic fatigue and ...
The main symptoms include fever, dry cough, and fatigue, may partially present with nasal congestion, runny nose, sore throat, decreased or lost sense of smell and/or taste, conjunctivitis, myalgia, and diarrhea. Patients were diagnosed as moderate COVID-19 when appearance of pneumonia signs on...
cough, dyspnea), GI symptoms, anosmia, ageusia; >seven days since index case of household contact had first positive COVID-19 test; taking hydroxychloroquine or remdesivir for any reason; enrolled in a COVID-19 prophylaxis study or receiving COVID-19 prophylaxis as standard of care, including ...
Recently, it has been reported that the S protein of SARS-CoV-2 binds to ACE2 with a higher affinity than SARS coronavirus, which might contribute to the rapid spread of COVID-19 [7]. Currently, it is unclear whether children’s low susceptibility to SARS-CoV-2 is related to the ...
people worldwide had been affected by whooping cough. During theCOVID-19pandemic there was a clear global decline in incidence, though by 2023 the disease was beginning to spread again; in the first six months of 2024, more cases were reported worldwide than for the entire year of 2023. ...
This case series describes clinical outcomes in 5 Chinese patients with laboratory-confirmed COVID-19, ARDS, and high viral loads despite antiviral
Invasive Fungal Sinusitis in Post COVID-19 Patients: A New Clinical Entity 2021, Laryngoscope COVID-19 and mucormycosis superinfection: the perfect storm 2021, Infection Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis 2019, British Journal of Ophthalmology Acute...
The Omicron variant was first identified in South Africa on 23 November 2021 after an uptick in the number of cases of COVID-19.[26] Omicron was quickly recognized as a VOC due to more than 30 changes to the spike protein of the virus and the sharp rise in the number of cases observe...
This cohort study examines the association of treatment with nirmatrelvir in the acute phase of COVID-19 and risk of post–COVID-19 condition.